Autosomal Dominant Polycystic Kidney Disease: 2026 Clinical Updates
ASN thanks the PKD Foundation for assistance with this program.
Course Description
ADPKD, the most common hereditary kidney disorder, is the fourth leading cause of ESKD and can cause life-threatening extrarenal manifestations. This program provides a comprehensive, case-based update on key aspects of ADPKD care, including the context of the 2025 KDIGO ADPKD guideline.
ASN designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Course Objective(s)
Upon completion of this program, the participant will be able to: 1) describe the approach to ADPKD diagnosis, classification, and prognosis prediction; 2) discuss renal and extrarenal manifestations of ADPKD and their management; 3) explain current pharmacologic approaches and supportive care for ADPKD; and 4) identify strategies for holistic ADPKD patient-centered care.
Course Chair(s)
Session(s)
- Autosomal Dominant Polycystic Kidney Disease: 2026 Clinical Updates
October 21, 2026 | 07:00 AM - 06:00 PM
Location: Room TBD, Convention Center |
Register for this Early Program
Early Programs have limited capacity and fill up fast. Click the button below to register online.